Literature DB >> 7882298

Diamine-oxidase activity and tissue di- and poly-amine contents of human ovarian, cervical and endometrial carcinoma.

R Chanda1, A K Ganguly.   

Abstract

In view of the conflicting reports regarding the association of di- and poly-amines along with diamine oxidase (DAO) activity in human carcinomatous growths, the present study was undertaken to establish their interrelation and to justify whether analysis of di- and poly-amine contents along with DAO may have any diagnostic value in the assessment of the carcinomatous state. It was found that diamines like histamine, putrescine and cadaverine, and polyamines like spermine and spermidine, and also DAO, increased unequivocally in human ovarian, cervical and endometrial carcinoma in comparison with their adjoining normal tissues. A reasonable explanation has been put forward to support the observations made.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882298     DOI: 10.1016/0304-3835(95)90153-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors.

Authors:  Peter M Szabó; Zoltán Wiener; Zsófia Tömböl; Attila Kovács; Péter Pócza; János Horányi; Janina Kulka; Peter Riesz; Miklós Tóth; Attila Patócs; Rolf C Gaillard; András Falus; Károly Rácz; Peter Igaz
Journal:  Virchows Arch       Date:  2009-07-01       Impact factor: 4.064

2.  Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma.

Authors:  Nabil M Abdel-Hamid; Amer Hasan Abdullah
Journal:  Clin Exp Med       Date:  2018-11-20       Impact factor: 3.984

Review 3.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer.

Authors:  Fabian B T Kraus; Nicole E Topalov; E Deuster; I Hysenaj; D Mayr; A Chelariu-Raicu; S Beyer; T Kolben; A Burges; S Mahner; F Trillsch; U Jeschke; B Czogalla
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-25       Impact factor: 4.553

5.  Neurotransmitter γ-aminobutyric acid-mediated inhibition of the invasive ability of cholangiocarcinoma cells.

Authors:  Qiang Huang; Chenhai Liu; Cheng Wang; Yuanguo Hu; Lujun Qiu; Peng Xu
Journal:  Oncol Lett       Date:  2011-03-04       Impact factor: 2.967

6.  Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens.

Authors:  Paul L Wood; M Amin Khan; Tara Smith; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-11-16       Impact factor: 3.876

7.  Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.

Authors:  Yi Wang; Yang Jiang; Jun-Ichiro Ikeda; Tian Tian; Atsushi Sato; Hiroshi Ohtsu; Eiichi Morii
Journal:  Cancer Med       Date:  2014-07-10       Impact factor: 4.452

8.  Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.

Authors:  Melisa B Nicoud; Karina Formoso; Vanina A Medina
Journal:  Front Pharmacol       Date:  2019-06-05       Impact factor: 5.810

Review 9.  G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules.

Authors:  Dragoș-Valentin Predescu; Sanda Maria Crețoiu; Dragoș Crețoiu; Luciana Alexandra Pavelescu; Nicolae Suciu; Beatrice Mihaela Radu; Silviu-Cristian Voinea
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

Review 10.  The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling.

Authors:  Adrienn Sipos; Gyula Ujlaki; Edit Mikó; Eszter Maka; Judit Szabó; Karen Uray; Zoárd Krasznai; Péter Bai
Journal:  Mol Med       Date:  2021-04-01       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.